cki 7 has been researched along with bi d1870 in 2 studies
| Studies (cki 7) | Trials (cki 7) | Recent Studies (post-2010) (cki 7) | Studies (bi d1870) | Trials (bi d1870) | Recent Studies (post-2010) (bi d1870) |
|---|---|---|---|---|---|
| 35 | 0 | 7 | 8 | 0 | 6 |
| Protein | Taxonomy | cki 7 (IC50) | bi d1870 (IC50) |
|---|---|---|---|
| MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | 0.5628 | |
| Casein kinase I isoform alpha | Homo sapiens (human) | 0.5525 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.5628 | |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | 0.4073 | |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | 0.5628 | |
| Serine/threonine-protein kinase 3 | Homo sapiens (human) | 0.5628 | |
| Ribosomal protein S6 kinase alpha-2 | Homo sapiens (human) | 0.4367 | |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | 0.017 | |
| Ribosomal protein S6 kinase alpha-1 | Rattus norvegicus (Norway rat) | 0.5145 | |
| Aurora kinase B | Homo sapiens (human) | 0.5628 | |
| Serine/threonine-protein kinase VRK1 | Homo sapiens (human) | 0.033 | |
| Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | 0.4361 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
| Feng, S; Ji, P; Li, GB; Ma, S; Sun, QZ; Wang, ZR; Yan, HX; Yang, LL; Yang, SY; Zou, J | 1 |
2 other study(ies) available for cki 7 and bi d1870
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization.
Topics: Casein Kinase I; Diamines; Dose-Response Relationship, Drug; Drug Discovery; High-Throughput Screening Assays; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship | 2012 |